Tenaya Therapeutics, Inc. (TNYA:NASDAQ) closed at $0.378 on October 19, 2026, down 0.81% on the day. The stock trades 81.3% below its 52-week high of $2.02 and 4.9% above its 52-week low of $0.360. Over the past year, it lost 80.8%. Tenaya Therapeutics, Inc. is part of the Health Care sector.
In 252 trading sessions since October 17, 2025, TNYA closed higher on 106 days (42%). Its best day was March 5, 2026 (+40.96%) and its worst was December 12, 2025 (-37.50%). The stock moved 10% or more in a single session 16 times.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.
Find more stocks like TNYA with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.